Drug level in human LNCaP cells xenografted NSG mouse kidney at 20 nmol, ip dosed on days 1, 4 and 7 measured 24 hrs after last dose by liquid scintillation counting method relative to single injection dose
Drug level in human LNCaP cells xenografted NSG mouse liver at 20 nmol, ip dosed on days 1, 4 and 7 measured 24 hrs after last dose by liquid scintillation counting method relative to single injection dose
Drug level in human LNCaP cells xenografted NSG mouse tumor at 20 nmol, ip measured after 24 hrs by liquid scintillation counting method relative to other tissues
Drug level in human LNCaP cells xenografted NSG mouse liver at 20 nmol, ip measured after 24 hrs by liquid scintillation counting method relative to kidney
Drug level in human LNCaP cells xenografted NSG mouse liver at 20 nmol, ip measured after 24 hrs by liquid scintillation counting method relative to lung
Drug level in human LNCaP cells xenografted NSG mouse tumor at 20 nmol, ip dosed on days 1, 4 and 7 measured 24 hrs after last dose by liquid scintillation counting method relative to single injection dose
Drug level in human LNCaP cells xenografted NSG mouse tumor at 20 nmol, ip measured after 4 hrs by liquid scintillation counting method relative to liver
Drug level in human LNCaP cells xenografted NSG mouse tumor at 20 nmol, ip measured after 24 hrs by liquid scintillation counting method relative to liver
Drug level in human LNCaP cells xenografted NSG mouse tumor at 20 nmol, ip dosed on days 1, 4 and 7 measured 24 hrs after last dose by liquid scintillation counting method